Skip NavigationMarketsBusinessInvestingTechPolitics & PolicyVideoWatchlistInvesting Club
PRO
LivestreamMenuEvery weekday, the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Monday’s key moments. 1. Stocks were mixed Monday as investors grew more skeptical that the U.S. and Iran will reach a lasting resolution to their military conflict anytime soon. Oil prices moved higher , with American benchmark West Texas Intermediate crude climbing back above $80 a barrel. Bond yields followed oil higher, which also put pressure on stocks. Investors were also looking ahead to Wednesday’s consumer price index after Friday’s weaker-than-expected jobs report reduced expectations for a Federal Reserve interest rate hike in September. Intel was a notable laggard, falling more than 3.5% after announcing plans to sell $15 billion of stock. Portfolio director Jeff Marks acknowledged the equity raise will dilute existing shareholders like us, but said the need for additional capital also reflects the strong demand Intel sees for its manufacturing, advanced packaging, and AI-related businesses. We decided after the Morning Meeting to buy more Intel . 2. Boeing agreed to sell three noncore subsidiaries — Wisk Aero, SkyGrid, and Insitu — to Archer Aviation for a roughly 20% stake in the company that makes electric vertical take-off and landing aircraft. Archer shares soared more than 13% on the deal. Jeff said the roughly $1 billion deal fits CEO Kelly Ortberg’s push to create a leaner, more focused Boeing by allowing the planemaker to concentrate on improving quality and ramping production and deliveries. Those efforts are key to generating stronger free cash flow, the centerpiece of our investment thesis. At the same time, the Archer deal allows Club name Boeing to retain exposure to these growth areas without having to operate those businesses itself. 3. Cardinal Health reports fiscal fourth-quarter earnings before Tuesday’s opening bell. The report follows strong results last week from fellow drug distributors Cencora and McKesson , both of which beat expectations and raised their full-year outlooks. Jeff said the key focus for Cardinal will be its fiscal 2027 guidance, with analysts expecting roughly 12% earnings-per-share (EPS) growth. He thinks that would be consistent with the company’s track record of delivering double-digit earnings growth. Shares have rebounded to near record highs after selling off sharply following Cardinal’s previous earnings report in May. We viewed that decline as a buying opportunity because the company’s fundamentals remained strong. Jeff said Cardinal remains “a good long-term story in our view.” (Jim Cramer’s Charitable Trust is long BA, CAH, INTC. See here for a full list of the stocks.) As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust’s portfolio. If Jim has talked about a stock on CNBC TV, he waits 72 hours after issuing the trade alert before executing the trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB. NO SPECIFIC OUTCOME OR PROFIT IS GUARANTEED.Read More
About The Author
